IHL 0.00% 4.1¢ incannex healthcare limited

we only need one trial to pass phase 3 and to get listed in US....

  1. 201 Posts.
    lightbulb Created with Sketch. 84
    we only need one trial to pass phase 3 and to get listed in US. The last part will happen by September this year. Even without US listing and only one trial to show good results we have a winner.
    all trials showed positive sings in vivo and backed by comprehensive research.
    Yes there is risk with one of the trials but we only need one to work to be the next GW pharma

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.